Regeneron Pharmaceuticals (NQ: REGN )
1,067.80
-17.82
(-1.64%)
Streaming Delayed Price
Updated: 3:20 PM EDT, Jul 18, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals![]()
What 8 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
January 30, 2023
Via Benzinga
![]() ![]() ![]()
Analyst Ratings for Regeneron Pharmaceuticals
January 11, 2023
Via Benzinga
![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
January 20, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Via Benzinga
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|